Head to Head Survey: Prestige Consumer Healthcare (NYSE:PBH) versus Merck & Co., Inc. (NYSE:MRK)



  • Summary:

     

    Merck & Co., Inc. (NYSE:MRK) and Prestige Consumer Healthcare (NYSE:PBH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.

    Earnings and Valuation

    This table compares Merck & Co., Inc. and Prestige Consumer Healthcare’s top-line revenue, earnings per share and valuation.

    Gross Revenue

    Price/Sales Ratio

    Net Income

    Earnings Per Share

    Price/Earnings Ratio

    Merck & Co., Inc.

    $42.29 billion

    5.51

    $6.22 billion

    $4.34

    21.09

    Prestige Consumer Healthcare

    $975.78 million

    2.12

    -$35.80 million

    $2.78

    14.80

    Merck & Co., Inc. has higher revenue and earnings than Prestige Consumer Healthcare. Pr ...

     

     

    Read Full News: https://rivertonroll.com/news/2020/01/16/head-to-head-review-prestige-consumer-healthcare-nysepbh-vs-merck-co-inc-nysemrk-updated-updated.html


Log in to reply